tiprankstipranks
Atossa Therapeutics (ATOS)
NASDAQ:ATOS
Holding ATOS?
Track your performance easily

Atossa Therapeutics (ATOS) Financial Statements

2,221 Followers

Atossa Therapeutics Financial Overview

Atossa Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.214; its P/E ratio is -4.49; Atossa Therapeutics is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is $-0.06. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -7.23M$ -6.05M$ -5.88M$ -7.75M$ -7.47M
EBITDA$ -7.23M$ -6.04M$ -5.87M$ -7.74M$ -7.46M
Net Income Common Stockholders$ -7.23M$ -6.05M$ -5.90M$ -7.76M$ -6.23M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 74.77M$ 79.53M$ 83.96M$ 88.46M$ 94.03M
Total Assets$ 79.48M$ 85.86M$ 91.09M$ 96.25M$ 101.69M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -74.77M$ -79.53M$ -83.96M$ -88.46M$ -94.03M
Total Liabilities$ 5.80M$ 5.70M$ 5.33M$ 5.24M$ 3.44M
Stockholders Equity$ 73.68M$ 80.16M$ 85.76M$ 91.02M$ 98.25M
Cash Flow-
Free Cash Flow$ -4.76M$ -4.53M$ -4.70M$ -5.57M$ -3.88M
Operating Cash Flow$ -4.75M$ -4.53M$ -4.70M$ -5.57M$ -3.88M
Investing Cash Flow$ -10.00K$ -3.00K$ -6.00K-$ -1.00K
Financing Cash Flow-$ 100.00K$ 204.00K-$ -1.48M
Currency in USD

Atossa Therapeutics Earnings and Revenue History

Atossa Therapeutics Debt to Assets

Atossa Therapeutics Cash Flow

Atossa Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis